Researcher comment: The PrE0505 study | Patrick Forde

(6:24)

Researcher comment: Updated KEYNOTE-426 data | Elizabeth Plimack

(1:46)

Researcher comment: The SAVOIR trial | Toni Choueiri

(4:24)

Researcher comment: Initial data from CCC19 | Jeremy Warner

(14:41)

Researcher comment: The VERTIS-CV trial | Chris Cannon

(7:17)

Researcher comment: COMPARE study | Hashim Ahmed

(5:37)

Researcher comment: The KEYNOTE-604 trial | Charles Rudin

(5:2)

Researcher comment: Ribociclib efficacy for visceral metastases | Denise Yardley

(8:55)

Write a Research Paper in No Time with Consensus AI | Writing literature review using Consensus

(11:19)

Researcher comment: The ADVOCATE trial | Peter Merkel

(8:9)

Researcher comment: Positive OS data for osimertinib in FLAURA trial | Suresh Ramalingam

(1:50)

Researcher comment: The KEYNOTE-355 trial | Javier Cortes

(5:37)

Researcher comment: Combining microRNAs and LDCT to assess lung cancer risk profiles | Ugo Pastorino

(3:10)

Researcher comment: The CONTROL trial | Laura Coates

(4:36)

Researcher comment: The DAPA-HF trial | John McMurray

(3:30)

Researcher comment: The DEFINE-HF trial | Mikhail Kosiborod

(5:49)

Researcher comment: PROfound improvement in outcomes with olaparib in mCRPC | Maha Hussain

(2:40)

Researcher comment: DECLARE-TIMI 58 | John Wilding

(5:50)

Researcher comment: Outcomes of rural breast cancer patients | Suneel Kamath

(5:32)

Researcher comment: Putting telehealth into practice for type 2 diabetes | Matthew Crowley

(13:8)